Status:
COMPLETED
Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Conditions:
Bursitis
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment
Eligibility Criteria
Inclusion
- Clinical diagnosis of anserine bursitis
Exclusion
- Intraarticular pathology that reflects pain in the medial part of the knee
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01205477
Start Date
September 1 2009
End Date
July 1 2010
Last Update
September 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario "José Eleuterio González"
Monterrey, Nuevo León, Mexico, 66024